Key Insights

Highlights

Treatment Research

6 treatments under study, led by Carbon Ion Radiotherapy

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Recruiting3
Not Yet Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07744074Not ApplicableRecruitingPrimary

Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors

NCT07035860Not Yet RecruitingPrimary

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

NCT06311955Phase 2Recruiting

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

NCT06831773Not ApplicableRecruitingPrimary

Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma

Showing all 4 trials

Research Network

Common Treatments

  • Carbon Ion Radiotherapy2
  • Chemotherapy1
  • Immunotherapy1
  • Combined With Platinumbased Regimen1
  • Carbon Ion Lattice Radioion Lattice Radiation Therapy For Thoracic Bulky Solid Tumors1

Active Sponsors

  • Ji Yongling2
  • Jian Chen1
  • Gansu Wuwei Tumor Hospital1

Top Investigators

Related Conditions

  • Heavy Ion Radiotherapy2
  • Highgrade Glioma1
  • Thymic Epithelial Tumor1
  • Radiotherapy Side Effect1

Activity Timeline